These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 30696850)
1. Structure, function, and inhibition of drug reactivating human gut microbial β-glucuronidases. Biernat KA; Pellock SJ; Bhatt AP; Bivins MM; Walton WG; Tran BNT; Wei L; Snider MC; Cesmat AP; Tripathy A; Erie DA; Redinbo MR Sci Rep; 2019 Jan; 9(1):825. PubMed ID: 30696850 [TBL] [Abstract][Full Text] [Related]
2. Three structurally and functionally distinct β-glucuronidases from the human gut microbe Pellock SJ; Walton WG; Biernat KA; Torres-Rivera D; Creekmore BC; Xu Y; Liu J; Tripathy A; Stewart LJ; Redinbo MR J Biol Chem; 2018 Nov; 293(48):18559-18573. PubMed ID: 30301767 [TBL] [Abstract][Full Text] [Related]
3. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. Ervin SM; Li H; Lim L; Roberts LR; Liang X; Mani S; Redinbo MR J Biol Chem; 2019 Dec; 294(49):18586-18599. PubMed ID: 31636122 [TBL] [Abstract][Full Text] [Related]
4. Discovery and Characterization of FMN-Binding β-Glucuronidases in the Human Gut Microbiome. Pellock SJ; Walton WG; Ervin SM; Torres-Rivera D; Creekmore BC; Bergan G; Dunn ZD; Li B; Tripathy A; Redinbo MR J Mol Biol; 2019 Mar; 431(5):970-980. PubMed ID: 30658055 [TBL] [Abstract][Full Text] [Related]
5. Amentoflavone from Selaginella tamariscina as a potent inhibitor of gut bacterial β-glucuronidase: Inhibition kinetics and molecular dynamics stimulation. Tian XG; Yan JK; Sun CP; Li JX; Ning J; Wang C; Huo XK; Zhao WY; Yu ZL; Feng L; Lv X; Ma XC Chem Biol Interact; 2021 May; 340():109453. PubMed ID: 33785314 [TBL] [Abstract][Full Text] [Related]
6. Substituent Position of Iminocyclitols Determines the Potency and Selectivity for Gut Microbial Xenobiotic-Reactivating Enzymes. Dashnyam P; Lin HY; Chen CY; Gao S; Yeh LF; Hsieh WC; Tu Z; Lin CH J Med Chem; 2020 May; 63(9):4617-4627. PubMed ID: 32105467 [TBL] [Abstract][Full Text] [Related]
7. Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling. Jariwala PB; Pellock SJ; Goldfarb D; Cloer EW; Artola M; Simpson JB; Bhatt AP; Walton WG; Roberts LR; Major MB; Davies GJ; Overkleeft HS; Redinbo MR ACS Chem Biol; 2020 Jan; 15(1):217-225. PubMed ID: 31774274 [TBL] [Abstract][Full Text] [Related]
8. Targeting Regorafenib-Induced Toxicity through Inhibition of Gut Microbial β-Glucuronidases. Ervin SM; Hanley RP; Lim L; Walton WG; Pearce KH; Bhatt AP; James LI; Redinbo MR ACS Chem Biol; 2019 Dec; 14(12):2737-2744. PubMed ID: 31663730 [TBL] [Abstract][Full Text] [Related]
9. Active site flexibility revealed in crystal structures of Parabacteroides merdae β-glucuronidase from the human gut microbiome. Little MS; Ervin SM; Walton WG; Tripathy A; Xu Y; Liu J; Redinbo MR Protein Sci; 2018 Dec; 27(12):2010-2022. PubMed ID: 30230652 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae. Little MS; Pellock SJ; Walton WG; Tripathy A; Redinbo MR Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E152-E161. PubMed ID: 29269393 [TBL] [Abstract][Full Text] [Related]
11. β-Glucuronidase Pattern Predicted From Gut Metagenomes Indicates Potentially Diversified Pharmacomicrobiomics. Candeliere F; Raimondi S; Ranieri R; Musmeci E; Zambon A; Amaretti A; Rossi M Front Microbiol; 2022; 13():826994. PubMed ID: 35308380 [TBL] [Abstract][Full Text] [Related]
12. Inhibition and structure-activity relationship of dietary flavones against three Loop 1-type human gut microbial β-glucuronidases. Wang P; Wu R; Jia Y; Tang P; Wei B; Zhang Q; Wang VY; Yan R Int J Biol Macromol; 2022 Nov; 220():1532-1544. PubMed ID: 36096258 [TBL] [Abstract][Full Text] [Related]
13. Gut microbial beta-glucuronidase and glycerol/diol dehydratase activity contribute to dietary heterocyclic amine biotransformation. Zhang J; Lacroix C; Wortmann E; Ruscheweyh HJ; Sunagawa S; Sturla SJ; Schwab C BMC Microbiol; 2019 May; 19(1):99. PubMed ID: 31096909 [TBL] [Abstract][Full Text] [Related]
14. Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics. Simpson JB; Walker ME; Sekela JJ; Ivey SM; Jariwala PB; Storch CM; Kowalewski ME; Graboski AL; Lietzan AD; Walton WG; Davis KA; Cloer EW; Borlandelli V; Hsiao YC; Roberts LR; Perlman DH; Liang X; Overkleeft HS; Bhatt AP; Lu K; Redinbo MR Cell Host Microbe; 2024 Jun; 32(6):925-944.e10. PubMed ID: 38754417 [TBL] [Abstract][Full Text] [Related]
15. Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10. Wei B; Wang PP; Yan ZX; Yan R Appl Microbiol Biotechnol; 2018 Nov; 102(21):9193-9205. PubMed ID: 30109395 [TBL] [Abstract][Full Text] [Related]
20. Selecting a Single Stereocenter: The Molecular Nuances That Differentiate β-Hexuronidases in the Human Gut Microbiome. Pellock SJ; Walton WG; Redinbo MR Biochemistry; 2019 Mar; 58(9):1311-1317. PubMed ID: 30729778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]